Literature DB >> 16527227

The effects of topical ketorolac and indomethacin on measles conjunctivitis: randomized controlled trial.

Mustafa Ilker Toker1, Hakan Erdem, Haydar Erdogan, Mustafa Kemal Arici, Aysen Topalkara, Osman Sevki Arslan, Alaaddin Pahsa.   

Abstract

PURPOSE: To compare the effect of topical ketorolac and indomethacin on measles conjunctivitis.
DESIGN: Prospective double-masked placebo-controlled randomized trial.
METHODS: Sixty-two patients with severe measles conjunctivitis were included in this study. All patients were hospitalized and randomly assigned to receive ketorolac 0.5% or indomethacin 0.1% in the right eye and artificial tears in the left eye. Conjunctival hyperemia, burning sensations, foreign-body sensations, and photophobia scores were conducted at baseline and at days seven and 14. A satisfaction score was evaluated at the end of the study.
RESULTS: The conjunctival injection score of the control eyes was significantly higher than those of the ketorolac- and indomethacin-treated eyes at day seven (P < .05). The conjunctival injection score of the ketorolac-treated eyes was lower than that of the indomethacin-treated eyes at days seven and 14, but this did not reach statistical significance. There was no significant difference in the burning and foreign-body sensations and in the photophobia scores among the study eyes at baseline, day seven, and day 14 (P > .05). There was no significant difference in the satisfaction score among the study eyes at the end of the study (P > .05).
CONCLUSIONS: In patients with measles during the first two weeks of infection, ketorolac and indomethacin were more effective than artificial tears in decreasing conjunctival hyperemia, but burning sensations, foreign-body sensations, and photophobia were unaffected.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16527227     DOI: 10.1016/j.ajo.2005.12.004

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

1.  Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues.

Authors:  Sai Prachetan Balguri; Goutham R Adelli; Soumyajit Majumdar
Journal:  Eur J Pharm Biopharm       Date:  2016-10-25       Impact factor: 5.571

2.  Energy-dependent endocytosis is responsible for drug transcorneal penetration following the instillation of ophthalmic formulations containing indomethacin nanoparticles.

Authors:  Noriaki Nagai; Fumihiko Ogata; Hiroko Otake; Yosuke Nakazawa; Naohito Kawasaki
Journal:  Int J Nanomedicine       Date:  2019-02-18

3.  Comparative study on the efficacy of non-steroidal, steroid and non-use of anti-inflammatory in the treatment of acute epidemic conjunctivitis.

Authors:  Luiz Alfredo Santiago; Jussara Matyelle Rodrigues da Silva; Orleâncio Gomes Ripardo de Azevedo; Paulo Roberto Leitão de Vasconcelos
Journal:  Acta Cir Bras       Date:  2020-02-07       Impact factor: 1.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.